AMRN
Amarin Corporation PLC
NASDAQ: AMRN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$14.29
+2.36% today
Updated 2026-04-29
Market cap
$292.10M
P/E ratio
—
P/S ratio
1.37x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$9 – $21
Volume
0.1M
Amarin Corporation PLC (AMRN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $46.76M | $48.83M | $42.25M | $36.66M | $56.20M | $35.37M | $126.38M | $310.86M | $252.48M | $171.11M | $173.46M | $167.00M | $161.60M | $385.71M | $882.21M | $966.02M | $1.07B | $886.18M | $831.68M | $685.35M |
| Cash & equivalents | $33.91M | $36.80M | $18.30M | $11.24M | $52.26M | $31.44M | $116.60M | $260.24M | $191.51M | $119.54M | $106.96M | $98.25M | $73.64M | $249.23M | $644.59M | $186.96M | $219.45M | $217.67M | $199.25M | $121.04M |
| Current assets | $36.67M | $39.59M | $21.73M | $16.14M | $56.05M | $33.11M | $118.97M | $285.69M | $219.40M | $145.28M | $143.52M | $146.33M | $153.27M | $378.00M | $855.00M | $879.23M | $878.73M | $689.10M | $724.98M | $595.40M |
| Total liabilities | $8.18M | $10.99M | $18.11M | $7.76M | $7.59M | $237.73M | $132.34M | $314.85M | $286.33M | $259.56M | $302.65M | $176.06M | $226.70M | $233.38M | $273.95M | $338.52M | $400.97M | $290.85M | $279.59M | $199.17M |
| Current liabilities | $8.00M | $10.76M | $15.41M | $7.11M | $6.69M | $7.58M | $8.45M | $25.20M | $37.54M | $40.31M | $50.72M | $76.25M | $108.53M | $157.26M | $242.25M | $307.44M | $370.68M | $259.48M | $259.28M | $179.95M |
| Long-term debt | $14000.00 | — | $2.09M | $24000.00 | $12000.00 | — | $13000.00 | $219.41M | $237.04M | $211.46M | $236.42M | $85.16M | $99.83M | $46.11M | — | — | — | — | — | — |
| Shareholder equity | $38.58M | $37.84M | $24.15M | $28.90M | $48.60M | $-202.37M | $-5.96M | $-4.00M | $-33.86M | $-88.45M | $-129.19M | $-9.06M | $-65.10M | $152.33M | $608.26M | $627.50M | $667.10M | $595.33M | $552.10M | $486.18M |
| Retained earnings | $-119.71M | $-144.43M | $-185.19M | $-203.77M | $-271.30M | $-499.33M | $-568.46M | $-747.64M | $-913.87M | $-970.23M | $-1.12B | $-1.20B | $-1.27B | $-1.39B | $-1.41B | $-1.43B | $-1.42B | $-1.53B | $-1.59B | $-1.67B |
| Accounts receivable | $2.08M | $1.62M | $1.70M | $674000.00 | $1.19M | — | — | $937000.00 | $3.65M | $7.84M | $13.83M | $19.98M | $45.32M | $66.52M | $116.43M | $154.57M | $163.65M | $130.99M | $133.56M | $122.28M |
| Inventory | — | $414000.00 | $881000.00 | — | — | — | — | $21.26M | $21.21M | $13.73M | $18.98M | $20.51M | $30.26M | $57.80M | $76.77M | $188.86M | $234.68M | $228.73M | $258.62M | $166.05M |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |